The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics
Open accessAbstract
Pharmacogenetics is frequently cited as an area for initial focus of the clinical implementation of genomics. Through the PG4KDS protocol, St. Jude Children's Research Hospital pre‐emptively genotypes patients for 230 genes using the Affymetrix Drug Metabolizing Enzymes and Transporters (DMET) Plus array supplemented with a CYP2D6 copy number assay. The PG4KDS protocol provides a rational, stepwise process for implementing gene/drug pairs, organizing data, and obtaining consent from patients and families. Through August 2013, 1,559 patients have been enrolled, and four gene tests have been released into the electronic health record (EHR) for clinical implementation: TPMT, CYP2D6, SLCO1B1, and CYP2C19. These genes are coupled to 12 high‐risk drugs. Of the 1,016 patients with genotype test results available, 78% of them had at least one high‐risk (i.e., actionable) genotype result placed in their EHR. Each diplotype result released to the EHR is coupled with an interpretive consult that is created in a concise, standardized format. To support‐gene based prescribing at the point of care, 55 interruptive clinical decision support (CDS) alerts were developed. Patients are informed of their genotyping result and its relevance to their medication use through a letter. Key elements necessary for our successful implementation have included strong institutional support, a knowledgeable clinical laboratory, a process to manage any incidental findings, a strategy to educate clinicians and patients, a process to return results, and extensive use of informatics, especially CDS. Our approach to pre‐emptive clinical pharmacogenetics has proven feasible, clinically useful, and scalable. © 2014 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Self-citationPharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Self-citationCPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
Relling, M. V., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.279 · Cited by 1,164
Self-citationPharmacogenetics: From Bench to Byte— An Update of Guidelines
Swen, J. J., Nijenhuis, M., de Boer, A., Grandia, L., Maitland-van der Zee, A. H., Mulder, H., Rongen, G. A. P. J. M., van Schaik, R. H. N., Schalekamp, T., Touw, D. J., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.34 · Cited by 1,018
Scott, S. A., Sangkuhl, K., Stein, C. M., Hulot, J.-S., Mega, J. L., Roden, D. M., Klein, T. E., Sabatine, M. S., Johnson, J. A., & Shuldiner, A. R. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.105 · Cited by 962
Charting a course for genomic medicine from base pairs to bedside
National Human Genome Research Institute, Green, E. D., & Guyer, M. S. (2011) · Nature · doi:10.1038/nature09764 · Cited by 902
Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations
Wolf, S. M., Lawrenz, F. P., Nelson, C. A., Kahn, J. P., Cho, M. K., Clayton, E. W., Fletcher, J. G., Georgieff, M. K., Hammerschmidt, D., Hudson, K., et al. (2008) · Journal of Law, Medicine & Ethics · doi:10.1111/j.1748-720x.2008.00266.x · Cited by 706
Wang, L., McLeod, H. L., & Weinshilboum, R. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1010600 · Cited by 613
Pharmacogenetics – five decades of therapeutic lessons from genetic diversity
Meyer, U. A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1428 · Cited by 420
Pulley, J. M., Denny, J. C., Peterson, J. F., Bernard, G. R., Vnencak-Jones, C. L., Ramirez, A. H., Delaney, J. T., Bowton, E., Brothers, K., Johnson, K., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.371 · Cited by 414
Crews, K. R., Gaedigk, A., Dunnenberger, H. M., Klein, T. E., Shen, D. D., Callaghan, J. T., Kharasch, E. D., & Skaar, T. C. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.287 · Cited by 371
Self-citationWilke, R. A., Ramsey, L. B., Johnson, S. G., Maxwell, W. D., McLeod, H. L., Voora, D., Krauss, R. M., Roden, D. M., Feng, Q., Cooper-DeHoff, R. M., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.57 · Cited by 332
Relling, M. V., Gardner, E. E., Sandborn, W. J., Schmiegelow, K., Pui, C.-H., Yee, S. W., Stein, C. M., Carrillo, M., Evans, W. E., Hicks, J. K., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.4 · Cited by 329
Self-citationAcute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy
Cheok, M. H., & Evans, W. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1800 · Cited by 217
Self-citationDevelopment and use of active clinical decision support for preemptive pharmacogenomics
Bell, G. C., Crews, K. R., Wilkinson, M. R., Haidar, C. E., Hicks, J. K., Baker, D. K., Kornegay, N. M., Yang, W., Cross, S. J., Howard, S. C., et al. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001993 · Cited by 208
Self-citationShuldiner, A. R., Relling, M. V., Peterson, J. F., Hicks, K., Freimuth, R. R., Sadee, W., Pereira, N. L., Roden, D. M., Johnson, J. A., & Klein, T. E. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.59 · Cited by 190
Self-citationDevelopment and implementation of a pharmacist-managed clinical pharmacogenetics service
Crews, K. R., Cross, S. J., McCormick, J. N., Baker, D. K., Molinelli, A. R., Mullins, R., Relling, M. V., & Hoffman, J. M. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100113 · Cited by 158
Self-citationThiopurine methyltransferase in acute lymphoblastic leukemia
Relling, M. V., Pui, C., Cheng, C., & Evans, W. E. (2006) · Blood · doi:10.1182/blood-2005-08-3379 · Cited by 130
Self-citationHicks, J. K., Crews, K. R., Hoffman, J. M., Kornegay, N. M., Wilkinson, M. R., Lorier, R., Stoddard, A., Yang, W., Smith, C. J., Fernandez, C. A., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.140 · Cited by 95
Self-citationClinical Pharmacology and Pharmacogenetics in a Genomics Era: The DMET Platform
Sissung, T. M., English, B. C., Venzon, D. J., Figg, W. D., & Deeken, J. F. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.154 · Cited by 87
Veenstra, D. L., Roth, J. A., Garrison, L. P., Ramsey, S. D., & Burke, W. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181eff533 · Cited by 86
Incidental Findings in Genetics Research Using Archived DNA
Clayton, E. W. (2008) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2008.00271.x · Cited by 68
Concordance of DMET Plus Genotyping Results With Those of Orthogonal Genotyping Methods
Fernandez, C. A., Smith, C. J., Yang, W., Lorier, R., Crews, K. R., Kornegay, N., Hicks, J. K., Stewart, C. F., Kawedia, J. D., Ramsey, L. B., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.95 · Cited by 49
Self-citationPersonal Genomic Measurements: The Opportunity for Information Integration
Altman, R. B. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.203 · Cited by 25
Evans, W. E., Crews, K. R., & Pui, C.-H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.9 · Cited by 24
Self-citationChallenges in the Pharmacogenomic Annotation of Whole Genomes
Altman, R. B., Whirl‐Carrillo, M., & Klein, T. E. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.111 · Cited by 24
Institutional Profile: A Hub for Bench-to-Bedside Pharmacogenomic-Based Research
Voora, D., & Ginsburg, G. S. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.62 · Cited by 6
Cited by
Caudle, K. E., Dunnenberger, H. M., Freimuth, R. R., Peterson, J. F., Burlison, J. D., Whirl-Carrillo, M., Scott, S. A., Rehm, H. L., Williams, M. S., Klein, T. E., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.87 · Cited by 571
Self-citationPreemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Dunnenberger, H. M., Crews, K. R., Hoffman, J. M., Caudle, K. E., Broeckel, U., Howard, S. C., Hunkler, R. J., Klein, T. E., Evans, W. E., & Relling, M. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124835 · Cited by 511
Self-citationYang, J. J., Landier, W., Yang, W., Liu, C., Hageman, L., Cheng, C., Pei, D., Chen, Y., Crews, K. R., Kornegay, N., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4671 · Cited by 445
Self-citationPersonalized Medicine and the Power of Electronic Health Records
Abul-Husn, N. S., & Kenny, E. E. (2019) · Cell · doi:10.1016/j.cell.2019.02.039 · Cited by 355
Pharmacogenomics: current status and future perspectives
Pirmohamed, M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00572-8 · Cited by 351
Metadata
- Authors
- Hoffman, J. M., Haidar, C. E., Wilkinson, M. R., Crews, K. R., Baker, D. K., Kornegay, N. M., Yang, W., Pui, C., Reiss, U. M., Gaur, A. H., Howard, S. C., Evans, W. E., Broeckel, U., & Relling, M. V.
- Venue
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Publisher
- Wiley
- Published
- 2014-03
- Volume
- 166
- Issue
- 1
- Pages
- 45-55
- ISSN
- 1552-4868 (ISSN-L)
- 1552-4876
- OpenAlex
- W1513910469
- Cited by
- 276
- References
- 28
- FWCI
- 30.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.